The small cap segment of the market has been on a steady rise, with the BSE Smallcap index showing a 1.03% increase today. In the last 5 days, this segment has seen a significant growth of 3.07%. This makes it the best performing segment across MCaps.

Among the top performers in this segment is Lincoln Pharma, with a remarkable return of 19.74%. However, not all stocks in this segment have seen positive growth. Granules India has been the worst performer with a return of -10.12%.

Despite this, the advance decline ratio of the stocks in this smallcap segment is quite impressive. Out of the 941 stocks, 661 have shown an upward trend while only 280 have declined. This gives a ratio of 2.36x, indicating a strong market sentiment towards small cap stocks.

In recent news, several stocks in this segment have had their scores upgraded. Cosmo First, Gabriel India, NCC, AGI Greenpac, and Affle India have all been upgraded from Hold to Buy. This shows the potential for growth in these stocks and highlights the positive outlook for the small cap segment in the market.

Investors looking for potential opportunities in the market should keep a close eye on the small cap segment, as it continues to show promising growth and potential for higher returns. With the right research and analysis, investors can make informed decisions and capitalize on the current market trends.